Skip to content
ORPHELIA Pharma
  • About us
  • Therapeutic Areas
    • Pipeline
    • Neurology
    • Oncology
  • Partners
  • News
  • Contact
×
  • About us
  • Therapeutic Areas
    • Pipeline
    • Neurology
    • Oncology
  • Partners
  • News
  • Contact
ORPHELIA Pharma

    Children with rare diseases
    deserve therapeutic answers

    Discover
    ORPHELIA Pharma

    Development of essential
    medicines in the field of rare
    pediatric diseases.
    Read more

    ORPHELIA Pharma’s mission

    Four key pillars :

    Latest news

    12 March 2025

    Orphelia Pharma provides update on KIZFIZO® regulatory submission with the European Medicines Agency

    Read More >
    18 November 2024

    Orphelia Pharma provides update on the regulatory submission of KIZFIZO® with the European Medicines Agency

    Read More >
    11 June 2024

    ORPHELIA Pharma to collaborate with Oscar Lambret clinical center to study KIZFIZO®, the first pediatric drinkable formulation of temozolomide, for the treatment of refractory or relapsed nephroblastoma (Wilms tumor)

    Read More >

    ORPHELIA Pharma
    85 boulevard Saint Michel
    75005 Paris – France
    Tel : +33 1 42 77 08 18
    Contact us

    • Politique de confidentialité
    • Data privacy policy
    ×
    • Politique de confidentialité
    • Data privacy policy